Organization
Botswana Harvard AIDS Institute Partnership
2 clinical trials
Clinical trial
Open-Label, Single-Arm, Phase 3b Study of the Incidence of Severe COVID-19 and Adverse Events Following AZD1222 COVID-19 Vaccination in Botswana Against SARS-CoV-2, AZD1222 - ESR-21-21311Status: Completed, Estimated PCD: 2022-12-30
Clinical trial
Contraceptives and Dolutegravir-based ARTStatus: Active (not recruiting), Estimated PCD: 2023-08-31